🇺🇸 FDA
Patent

US 10450384

Compositions of alpha-1 antitrypsin fusion molecules

granted A61KA61K38/57A61P

Quick answer

US patent 10450384 (Compositions of alpha-1 antitrypsin fusion molecules) held by The Regents of the University of Colorado expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/57, A61P, A61P13/08, A61P15/10